Methylamine

Methylamine

SCHEMBL4944403

[2H]NC

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylamine SCHEMBL29128734 0.93
Methylamine SCHEMBL13522273 0.83
Methylamine SCHEMBL30965136 0.72
Methylamine SCHEMBL1751566 0.58
Hydrazine SCHEMBL13889965 0.55
Hydrazine SCHEMBL2350819 0.55
Hydrazine SCHEMBL4096587 0.55
SCHEMBL12061307 0.50
SCHEMBL8491323 0.50
Methylamine SCHEMBL1332656 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117384136-A NO donor type antifungal compound and preparation method and application thereof 中国药科大学 2024-01-12 CN claimed
CN-111302951-B N-deuterium methyl amine compound and preparation method thereof 深圳大学 2023-10-17 CN claimed
EP-4630414-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN Captor Therapeutics S.A. (PL) 2025-10-15 EP disclosed
WO-2024121256-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2024-06-13 WO disclosed
CN-117384136-A NO donor type antifungal compound and preparation method and application thereof 中国药科大学 2024-01-12 CN disclosed
CN-111302951-B N-deuterium methyl amine compound and preparation method thereof 深圳大学 2023-10-17 CN disclosed
CN-116217578-A Bifunctional compound for inhibiting mTOR and simultaneously degrading GSPT1 protein 清华大学 2023-06-06 CN disclosed
EP-4121045-A1 CRYSTALLINE NORPSILOCIN COMPOUNDS Caamtech, Inc. (US) 2023-01-25 EP disclosed
CN-111302951-A N-deuterium methyl amine compound and preparation method thereof 深圳大学 2020-06-19 CN disclosed
US-20170129882-A1 INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 CELGENE QUANTICEL RESEARCH, INC. (US) 2017-05-11 US disclosed
US-20160042875-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, AND METAL COMPLEX DYE USED IN SAME FUJIFILM CORPORATION (JP) 2016-02-11 US disclosed
US-20140296212-A1 SUBSTITUTED PHENOXYPROPYLCYCLOAMINE DERIVATIVES AS HISTAMINE-3 (H3) RECEPTOR LIGANDS CEPHALON, INC. (US) 2014-10-02 US disclosed
US-8648067-B2 Substituted phenoxypropylcycloamine derivatives as histamine-3 (H3) receptor ligands CEPHALON, INC. (US) 2014-02-11 US disclosed
CN-102803222-A Method and process for preparation and production of deuterated omega-diphenylurea SUZHOU ZELGEN BIOPHARMACEUTICAL CO LTD 2012-11-28 CN disclosed
CN-102803220-A Synthetic method of fluorine-containing deuterated diphenylurea SUZHOU ZELGEN BIOPHARMACEUTICAL CO LTD 2012-11-28 CN disclosed
CN-102803221-A Deuterated omega-diphenylurea and derivatives thereof and pharmaceutical compositions containing these compounds SUZHOU ZELGEN BIOPHARMACEUTICAL CO LTD 2012-11-28 CN disclosed
US-20120238551-A1 Substituted Phenoxypropylcycloamine Derivatives as Histamine-3 (H3) Receptor Ligands CEPHALON FRANCE (FR) 2012-09-20 US disclosed
US-20110008447-A1 CARRIER COMPRISING NANODIAMOND NATIONAL CHIAO TUNG UNIVERSITY (TW) 2011-01-13 US disclosed
EP-1909576-A2 NOVEL PHARMACEUTICAL COMPOUNDS Concert Pharmaceuticals Inc. (US) 2008-04-16 EP disclosed
WO-2007016361-A2 NOVEL PHARMACEUTICAL COMPOUNDS CONCERT PHARMACEUTICALS INC. (US) 2007-02-08 WO disclosed